Table 1 Clinical characteristics
Characteristics | Total (n = 402) |
|---|---|
Age, years | 57.6 ± 10.0 |
Traditional risk factors, n (%) | |
Advanced age (≥ 60 years) | 172 (42.8) |
Male | 198 (49.3) |
Hypertension | 173 (43.0) |
Diabetes mellitus | 52 (12.9) |
Metformin use | 20 (5.0) |
Insulin use | 6 (1.5) |
Hyperlipidemia | 137 (34.1) |
Obesity | 173 (43.0) |
Current smoking | 58 (14.4) |
At baseline CCTA | |
BMI, kg/m2 | 24.9 ± 3.2 |
SBP, mmHg | 127.1 ± 18.5 |
DBP, mmHg | 77.2 ± 10.9 |
Total cholesterol, mg/dL | 189.6 ± 41.3 |
Triglyceride, mg/dL | 136.2 ± 75.4 |
HDL-C, mg/dL | 51.7 ± 13.7 |
LDL-C, mg/dL | 116.3 ± 33.8 |
Creatinine, mg/dL | 0.98 ± 0.73 |
Glucose, mg/dL | 105.4 ± 31.9 |
Hemoglobin A1C, % | 6.3 ± 1.3 |
Statin use, n (%) | 121 (30.0) |
At follow-up CCTA | |
BMI, kg/m2 | 25.1 ± 3.3 |
SBP, mmHg | 125.8 ± 17.6 |
DBP, mmHg | 76.3 ± 10.5 |
Total cholesterol, mg/dL | 178.8 ± 38.7* |
Triglyceride, mg/dL | 135.1 ± 93.7 |
HDL-C, mg/dL | 50.6 ± 13.5* |
LDL-C, mg/dL | 105.4 ± 31.9* |
Creatinine, mg/dL | 0.90 ± 0.50* |
Glucose, mg/dL | 106.7 ± 33.7 |
Hemoglobin A1C, % | 6.3 ± 1.1 |
Statin use, n (%) | 182 (45.3) |
Follow-up CCTA findings | |
Newly developed plaque, n (%) | 143 (35.6) |
RPP, n (%) | 17 (4.2) |
Plaque volume, mm3 | |
Total | 12.98 ± 32.71 |
Fibrous | 7.04 ± 19.62 |
Fibrous-fatty | 2.99 ± 10.23 |
Necrotic core | 0.44 ± 2.63 |
Dense calcium | 2.49 ± 8.90 |